MarginsXMarginsX
Home › Markets › Health Care › TFX

Teleflex Incorporated (TFX)

TFX trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$157.10
+1.51% on the day
Market cap
$6.2B
Mid cap
Revenue · 2025
$2.0B
+17.2% on 2024
Net income · 2025
-$905.6M
-45.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/0000096943-26-000019-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerTFX on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000096943
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.0B
Net income-$905.6M
Operating income$118.4M
Net margin-45.4%
Operating margin5.9%
Revenue growth+17.2%
Cash$378.6M
Total assets$6.9B
P/E (computed)Net income was not positive
P/S (computed)3.1×

Warning signs

Cash runway
Cash-flow positive
$430.5M cash at September 30, 2026
Share count, 1 year
-10.3%
2025-11-04 to 2026-11-03 · -15.6% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$430.5M cash; operating cash flow $80.3M a quarter.Report 2026-09-30
Shares outstanding39,661,261 (2026-11-03); 44,194,408 a year earlier; 46,992,664 three years earlier.Cover page 2026-11-03
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Philadelphia, Pennsylvania, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$567.8M$927.4M$96.3M$430.5M$1.6B$2.3B10-Q 2026-11-05
Q2 2026
2026-06-30
$570.3M$99.7M$91.9M$300.2M$2.8B$2.3B10-Q 2026-08-06
Q1 2026
2026-03-31
$548.3M-$8.2M$46.7M$309.4M$2.6B$2.1B10-Q 2026-05-07
Q4 2025
2025-12-31
$569.0M-$714.3M$86.4M$378.6M$2.6B$2.0B10-K 2026-02-27
Q3 2025
2025-09-28
$566.9M-$408.9M$19.6M$354.0M$2.7B$1.9B10-Q 2026-11-05
Q2 2025
2025-06-29
$442.5M$122.6M-$37.0M$253.7M$1.9B$1.7B10-Q 2026-08-06
Q1 2025
2025-03-30
$414.3M$95.0M$27.7M$284.1M$1.9B$1.7B10-Q 2026-05-07
Q4 2024
2024-12-31
$442.0M-$136.7M-$133.7M$247.9M$1.7B$1.7B10-K 2026-02-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52017-11-17
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEF 14A2026-04-13

Source: SEC EDGAR submissions feed, 1,008 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+2.8%
1 month+24.6%
3 months+12.9%
Year to date+27.1%
1 year+41.7%
From 52-week high-0.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
HAEHaemonetics Corporation$121.34-1.30%$5.5B
MMEDMiniMed Group Inc.$18.65+3.67%$5.2B
MMSIMerit Medical Systems Inc.$86.35-0.32%$5.2B
ICUIICU Medical Inc.$181.87+1.45%$4.5B
STVNStevanato Group S.p.A.$15.53-1.71%$4.2B
GMEDGlobus Medical Inc.$70.50-2.27%$9.3B
HTFLHeartflow Inc.$46.86-3.30%$4.1B
NVSTEnvista Holdings Corporation$24.03-1.88%$3.9B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier